Medical oncologist Dana Rathkopf designs clinical trials that test new drugs directed at molecular pathways of disease in prostate cancer.
Our Department of Medicine comprises experts in medical oncology and nearly all internal medicine subspecialties. Chemotherapy and biologic treatments for cancer are a major aspect of the care that we provide, but our many specialists also provide and oversee comprehensive care that addresses our patients’ comorbidities, treatment side effects, palliative medicine, and survivorship issues.
